Center for Health Policy

CMS Will Cover New Colorectal Cancer Screening Tool

The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is sufficient to cover Cologuard – a multitarget stool DNA test – as a colorectal cancer screening test for asymptomatic, average risk beneficiaries, aged 50 to 85 years.
Therefore, Medicare Part B will cover the Cologuard test once every three years for beneficiaries who meet certain criteria.

Read the full decision memo here.